期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Progressively Enlarging Goiter:Case Reports of Primary Thyroid Lymphoma and Literature Review 被引量:3
1
作者 Xia-ming LIU de-lin ma +1 位作者 Gang YUAN Jun-hui XIE 《Current Medical Science》 SCIE CAS 2020年第3期518-522,共5页
Primary thyroid lymphoma(PTL)is an exceptionally rare and highly aggressive potentially curable malignant disease.We report three typical cases of PTL referred to our hospital.All three cases had long history of Hashi... Primary thyroid lymphoma(PTL)is an exceptionally rare and highly aggressive potentially curable malignant disease.We report three typical cases of PTL referred to our hospital.All three cases had long history of Hashimoto’s thyroiditis,and presented with progressively enlarging neck mass.The first two cases were confirmed by surgical biopsy to be diffuse large B cell lymphoma,and received radiotherapy combined with chemotherapy,or received only chemotherapy.The third case was confirmed by core needle biopsy to be mucosa-associated lymphoid tissue lymphoma,and received radiotherapy.In summary,confirmation of PTL diagnosis is essential for further clinical decisions.Core biopsy should be one of the most important methods to make the diagnosis of PTL,while the use of fine needle aspiration cytology alone is still limited in diagnosing PTL. 展开更多
关键词 primary thyroid lymphoma B-cell lymphoma Hashimoto’s thyroiditis fine needle aspiration cytology core needle biopsy
下载PDF
The presence of intraductal carcinoma of the prostate is closely associated with poor prognosis:a systematic review and meta-analysis 被引量:1
2
作者 Yu-Cong Zhang Guo-Liang Sun +8 位作者 de-lin ma Chao Wei Hao-Jie Shang Zhuo Liu Rui Li Tao Wang Shao-Gang Wang Ji-Hong Liu Xia-Ming Liu 《Asian Journal of Andrology》 SCIE CAS CSCD 2021年第1期103-108,共6页
We aimed to confirm the predictive ability of the presence of intraductal carcinoma of the prostate(IDC-P)for prognosis and the associations between IDC-P and clinicopathological parameters.Studies were identified in ... We aimed to confirm the predictive ability of the presence of intraductal carcinoma of the prostate(IDC-P)for prognosis and the associations between IDC-P and clinicopathological parameters.Studies were identified in PubMed,Cochrane Library,EMBASE,Web of Science,and SCOPUS up to December 1,2019.Hazard ratios(HRs)for survival data and odds ratios for clinicopathological data with 95%confidence intervals(CIs)were extracted.Heterogeneity was evaluated by the I2 value,and quality was assessed by the Newcastle-Ottawa Scale criteria.A total of 4179 patients from 13 studies were included.The results showed that IDC-P presence was significantly associated with poor progression-free survival(PFS;HR=2.31;95%Cl:1.96-2.73),cancer-specific survival(HR=1.89;95%Cl:1.28-2.77),and overall survival(HR=2.14;95%Cl:1.53-3.01).In the subgroup analysis,IDC-P presence was significantly associated with poor PFS in prostate cancer treated by radical prostatectomy(HR=2.48;95%Cl:2.05-3.00)and treated by radiotherapy(HR=2.83;95%Cl:1.65-4.85).Regarding clinicopathological characteristics,patients with IDC-P presence had significantly higher tumor clinical stages,Gleason scores,probabilities of lymph node invasion,positive surgical margins,and positive extraprostatic extension.Our meta-analysis indicates that the presence of IDC-P is closely associated with poor prognosis and adverse clinicopathological characteristics.Our data support the value and clinical utility of the routine detection of IDC-P by pathological examination.These conclusions need further validation,and prospective studies are needed to find better treatment modalities other than traditional first-line therapy for patients with IDC-P. 展开更多
关键词 CLINICOPATHOLOGICAL intraductal carcinoma of the prostate META-ANALYSIS PROGNOSTIC prostate cancer
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部